GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 723 filers reported holding GLAXOSMITHKLINE PLC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $311,000 | -6.3% | 7,142 | -6.2% | 0.01% | +14.3% |
Q1 2022 | $332,000 | +16.5% | 7,616 | +0.6% | 0.01% | -12.5% |
Q3 2020 | $285,000 | +2.9% | 7,574 | +3.8% | 0.01% | -27.3% |
Q1 2020 | $277,000 | -29.3% | 7,299 | -12.6% | 0.01% | -8.3% |
Q4 2019 | $392,000 | +15.0% | 8,349 | +4.7% | 0.01% | +9.1% |
Q3 2019 | $341,000 | +6.9% | 7,978 | 0.0% | 0.01% | 0.0% |
Q2 2019 | $319,000 | -3.0% | 7,978 | +1.4% | 0.01% | 0.0% |
Q1 2019 | $329,000 | +17.1% | 7,864 | +7.0% | 0.01% | 0.0% |
Q4 2018 | $281,000 | +8.5% | 7,347 | +13.8% | 0.01% | +22.2% |
Q3 2018 | $259,000 | +13.1% | 6,455 | +30.3% | 0.01% | -10.0% |
Q1 2015 | $229,000 | +8.0% | 4,953 | 0.0% | 0.01% | 0.0% |
Q4 2014 | $212,000 | -11.7% | 4,953 | -4.9% | 0.01% | -9.1% |
Q3 2014 | $240,000 | -11.4% | 5,210 | +2.7% | 0.01% | -15.4% |
Q2 2014 | $271,000 | -1.8% | 5,071 | -1.9% | 0.01% | -7.1% |
Q1 2014 | $276,000 | -8.9% | 5,171 | -8.8% | 0.01% | -12.5% |
Q4 2013 | $303,000 | -0.3% | 5,671 | -6.5% | 0.02% | -11.1% |
Q3 2013 | $304,000 | +28.8% | 6,063 | +28.6% | 0.02% | +20.0% |
Q2 2013 | $236,000 | – | 4,713 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |